JENVAC
₹990.00
Description
JENVAC ® is an inactivated Vero cell- derived vaccine prepared from an Indian strain of the Japanese encephalitis virus. JENVAC® is safe and highly effective vaccine that protects against all the known strains of Japanese encephalitis. It is approved for use in children and adults above one year of age. It is routinely used by people living in endemic areas or areas where recent breakout of JE epidemic is reported. It should also be used in children and adults traveling into areas where JE is endemic, spending a month or longer in endemic areas during the transmission season, especially if travel will include rural areas. It is an optional vaccine meant for restricted high risk states.
Children:
It is licensed to be used in children of age 12 months or more. Two doses of 0.5 ml of the vaccine is given at minimum interval of 28 days. Booster dose can be given after 1 year if child is residing in endemic area.
Adults:
Two doses of 0.5 ml of the vaccine is given at minimum interval of 28 days. Booster dose can be given after 1 year if person is residing in endemic area.
Additional information
country-of-manufacture | India |
---|---|
manufacturer | Bharat Biotech |
minimum-age | 1 Year |
package-size | 1 Dose, 5 Dose |
pharmaceutical-form | Ready to Use |
preservative | Thiomersal |
route-of-administration | Intramuscular |
vaccine-type | Japanese Encephalitis |
Contraindications | Further doses of vaccine are contraindicated if rare cases of anaphylactic reactions following the administration of the vaccine occurs. Intramuscular vaccines should not be given to persons with thrombocytopenia, haemophilia or other bleeding disorders. JEEV should not be given to pregnant and lactating mothers. |